We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Citing Part 11 Reveals FDA's Enforcement Position, Experts Say
Warning Letter Citing Part 11 Reveals FDA's Enforcement Position, Experts Say
May 25, 2005
A recent warning letter citing 21 CFR Part 11 validation and control requirements is a clear signal that the FDA will enforce the electronic records and signatures regulation even as the agency moves toward revising it, industry experts say.